cyclopamine (Compound)

Synonyms:CYCLOPAMINE, 4449-51-8, 11-Deoxojervine, 11-Deoxyjervine, Jervine, 11-deoxo-, CHEBI:4021, CHEMBL254129, DTXSID6043709, ZH658AJ192, NSC-734950, Cyclopamine Tartrate, C27H41NO2, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)- (9CI), (3beta,22S,23R)-17,23-epoxyveratraman-3-ol, UNII-ZH658AJ192, HSDB 3505, CY8, [3H]-Cyclopamine, MFCD09878269, CYCLOPAMINE [MI], 1178510-81-0, CYCLOPAMINE [HSDB], SCHEMBL29153, BSPBio_001032, MLS006010945, Veratraman-3-ol, 17,23-epoxy-, (3beta,23beta)-, DTXCID4023709, GTPL10328, EX-A952, BCPP000271, HMS1792D13, HMS1990D13, HMS3403D13, Tox21_300632, BDBM50232973, HB2965, NSC734950, s1146, AKOS024456709, BCP9000568, CCG-208181, CS-0633, NSC 734950, NCGC00163474-03, NCGC00163474-04, NCGC00163474-07, NCGC00254431-01, AC-34305, HY-17024, SMR001822854, CAS-4449-51-8, (3beta23R)-17,23-Epoxyveratraman-3-ol, F16272, SR-05000002357, Veratraman-3-ol,23-epoxy-, (3-beta,23-beta)-, Q-200904, Q3271319, SR-05000002357-2, BRD-K58938839-001-03-8, Veratraman-3-ol, 17,23-epoxy-, (3-beta,23-beta)-, Z3243808232, (2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11,11a,11b-octadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-3-ol, 11051-96-0, Spiro(9H-benzo(a)fluorene-9,2-b)pyridin)-3-o l, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octa deca hydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-, Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (3S,3'R,3a'S,6'S,6aS,6bS,7a'R,9R,11aS,11bR)-

Pubchem:PUBCHEM:442972

Id:c4f4ac31-2841-5e09-9ae8-82a4daebbfa9

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View cyclopamine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for cyclopamine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with cyclopamine.

Results found

Linked to

	Label	Description
	BRD-K58938839-001-03-8 Substance (Entity type)	A Substance
	cyclopamine (a35c9832-6b25-42ed-a630-2de7f80eb8f8) Collection (Entity type)	Metadatata for cyclopamine
	cyclopamine (b8e4c8d4-5dc8-4dac-affc-13b5061395bf) Collection (Entity type)	Metadatata for cyclopamine
	cyclopamine positively regulates MSMO1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cyclopamine in similarity relationship with (4,5-bis(4-methoxyphenyl)thiazol-2-yl)(4-methylpiperazin-1-yl)methanone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cyclopamine negatively regulates CHI3L1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cyclopamine bioactivity Sonic hedgehog protein Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	cyclopamine positively regulates TPSAB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cyclopamine in similarity relationship with CAM-9-027-3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cyclopamine positively regulates CFD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS